Melanoma Journal Articles for April 2019

Nature Communications

Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5^?/^? mice

Yan Li, Roberto Tinoco, Lisa Elmén, Igor Segota, Yibo Xian, Yu Fujita, Avinash Sahu, Raphy Zarecki, Kerrie Marie, Yongmei Feng, Ali Khateb, Dennie T. Frederick, Shiri K. Ashkenazi, Hyungsoo Kim, Eva Guijarro Perez, Chi-Ping Day, Rafael S. Segura Muñoz, Robert Schmaltz, Shibu Yooseph, Miguel A. Tam, Tongwu Zhang, Emily Avitan-Hersh, Lihi Tzur, Shoshana Roizman, Ilanit Boyango, Gil Bar-Sela, Amir Orian, Randal J. Kaufman, Marcus Bosenberg, Colin R. Goding, Bas Baaten, Mitchell P. Levesque, Reinhard Dummer, Kevin Brown, Glenn Merlino, Eytan Ruppin, Keith Flaherty, Amanda Ramer-Tait, Tao Long, Scott N. Peterson, Linda M. Bradley & Ze’ev A. Ronai

Nature Communications volume 10, Article number: 1492 (2019)

Published 2^nd April 2019

Cancer Medicine

Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma

Yasuhiro Fujisawa, Shusuke Yoshikawa, Akane Minagawa, Tatsuya Takenouchi, Kenji Yokota, Hiroshi Uchi, Naoki Noma, Yasuhiro Nakamura, Jun Asai, Junji Kato, Susumu Fujiwara, et al

First published: 01 April 2019

https://doi.org/10.1002/cam4.2110

Cancer Discovery

Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases

Grant M. Fischer, Ali Jalali, David A. Kircher, Won-Chul Lee, Jennifer L. McQuade, Lauren E. Haydu, Aron Y. Joon, Alexandre Reuben, Mariana P. de Macedo, Fernando C. L. Carapeto, Chendong Yang, Anuj Srivastava, Chandrashekar R. Ambati, Arun Sreekumar, Courtney W. Hudgens, Barbara Knighton, Wanleng Deng, Sherise D. Ferguson, Hussein A. Tawbi, Isabella C. Glitza, Jeffrey E. Gershenwald, Y. N. Vashisht Gopal, Patrick Hwu, Jason T. Huse, Jennifer A. Wargo, P. Andrew Futreal, Nagireddy Putluri, Alexander J. Lazar, Ralph J. DeBerardinis, Joseph R. Marszalek, Jianjun Zhang, Sheri L. Holmen, Michael T. Tetzlaff and Michael A. Davies

DOI: 10.1158/2159-8290.CD-18-1489

Published OnlineFirst April 4, 2019
doi: 10.1158/2159-8290.CD-18-1489

The Journal of Biological Chemistry

WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial–mesenchymal transition

Wentao Deng^‡,^§, Audry Fernandez^‡,^§, Sarah L. McLaughlin^§,^¶ andDavid J. Klinke II^‡,^§,^?¹

First Published on February 5, 2019 doi: 10.1074/jbc.RA118.006122 April 5, 2019 The Journal of Biological Chemistry294, 5261-5280.

Annals of Surgical Oncology

Robotic-Assisted Pelvic Lymphadenectomy for Metastatic Melanoma Results in Durable Oncologic Outcomes

John T. Miura, Lesly A. Dossett, Ram Thapa, Youngchul Kim, Aishwarya Potdar, Hala Daou, James Sun, Amod A. Sarnaik, Jonathan S. Zager

First Online: 04 April 2019

Nuclear Medicine and Molecular Imaging

Original Research

Tumor Heterogeneity on FDG PET/CT and Immunotherapy: An Imaging Biomarker for Predicting Treatment Response in Patients With Metastatic Melanoma

Sanli¹, J. Leake¹, A. Odu¹, Y. Xi¹and R. M. Subramaniam

Dove Press

PEGylated and CD47-conjugated nanoellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor T-cell responses

Authors Song S, Jin X, Zhang L, Zhao C, Ding Y, Ang Q, Khaidav O, Shen C

Received 24 November 2018

Accepted for publication 27 February 2019

Published 8 April 2019 Volume 2019:14 Pages 2465—2483

DOI https://doi.org/10.2147/IJN.S195828

Human Pathology

Stromal inflammatory cells are associated with poorer prognosis in primary cutaneous melanoma

Sook JungYun MD PhD^a ShujingLiu^b MeghanBuckley^c TaoWangPhD^d SunaJin^a GiorgosKarakousisMD^e Madalyn G.Peters^e David E.ElderMB ChB FRCPA^b Phyllis A.GimottyPhD^c XiaoweiXuMD PhD^b

https://doi.org/10.1016/j.humpath.2019.03.008

Available online 6 April 2019

Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis

Terje Sundstrøm, Lars Prestegarden, Francisco Azuaje, Synnøve Nymark Aasen, Gro Vatne Røsland, Jobin K. Varughese, Marzieh Bahador, Simon Bernatz, Yannick Braun, Patrick N. Harter, Kai Ove Skaftnesmo, Elizabeth S. Ingham, Lisa M. Mahakian, Sarah Tam, Clifford G. Tepper, Kjell Petersen, Katherine W. Ferrara, Karl Johan Tronstad, Morten Lund-Johansen, Rudi Beschorner, Rolf Bjerkvig^† and Frits Thorsen^†

^†Contributed equally

Acta Neuropathologica Communications20197:55

https://doi.org/10.1186/s40478-019-0712-8

Received: 7 March 2019
Accepted: 27 March 2019
Published: 10 April 2019

Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis

^†Contributed equally

Acta Neuropathologica Communications20197:55

https://doi.org/10.1186/s40478-019-0712-8

Received: 7 March 2019
Accepted: 27 March 2019
Published: 10 April 2019

Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity

Giuseppe Minniti, Dimitri Anzellini, Chiara Reverberi, Gian Carlo Antonini Cappellini, Luca Marchetti, Federico Bianciardi, Alessandro Bozzao, Mattia Osti, Pier Carlo Gentile and Vincenzo Esposito

Journal for ImmunoTherapy of Cancer20197:102

https://doi.org/10.1186/s40425-019-0588-y

Received: 22 November 2018
Accepted: 2 April 2019
Published: 11 April 2019

Br J Dermatol. 2019 Apr 9. doi: 10.1111/bjd.17990. [Epub ahead of print]

Benefits of a brief psychological intervention targeting fear of cancer recurrence in people at high risk of developing another melanoma: 12-month follow-up results of a randomised controlled trial.

Dieng M^1,2, Morton RL¹, Costa DSJ³, Butow PN⁴, Menzies SW^5,6, Lo S^7,8, Mann GJ^7,9, Cust AE^2,7, Kasparian NA^7,10,11.

International Journal of Dermatology

Wide local excision prior to sentinel lymph node biopsy for primary melanoma of the head and neck

Matthew M. May MD, Christine M. Lohse MS, Eric J. Moore MD, Daniel L. Price MD, Kathryn M. Van Abel MD, Jerry D. Brewer MD, MS, Jeffrey R. Janus MD

First published: 10 April 2019

https://doi.org/10.1111/ijd.14435

BioRxiv

SPINT1 regulates the aggressiveness of skin cutaneous melanoma and its crosstalk with tumor immune microenvironment

Elena Gomez-Abenza, Sofia Ibanez-Molero, Diana Garcia-Moreno, Inmaculada Fuentes-Martinez, View ORCID ProfileLeonard Zon, View ORCID ProfileMaria Caterina Mione, View ORCID ProfileMaria L. Cayuela, View ORCID ProfileChiara Gabellini, View ORCID ProfileVictoriano Mulero

doi: https://doi.org/10.1101/611145

Posted April 16, 2019

Head & Neck

Patterns of recurrence and retreatment outcomes among clinical stage I and II head and neck melanoma patients

Arya W. Namin MD, Georgeanne E. Cornell BS, Lori A. Thombs PhD, Robert P. Zitsch III MD

First published: 10 January 2019

https://doi.org/10.1002/hed.25562

Future Medicine

Application of CO₂ laser evaporation in locally advanced melanoma

Otis M Vrielink, Schelto Kruijff, Barbara L van Leeuwen & Jan LN Roodenburg

Published Online:18 Apr 2019 https://doi.org/10.2217/mmt-2018-0008

Future Medicine

Hypophysitis induced by immune checkpoint inhibitors in a Scottish melanoma population

Khor Zhong Wei, Mark Baxter & Richard Casasola

Published Online:18 Apr 2019https://doi.org/10.2217/mmt-2018-0009

J Cell Biochem. 2019;1-13. DOI: 10.1002/jcb.28600

The Laryngoscope

Head and Neck

Contrast?Enhanced Ultrasound With Perflubutane for Sentinel Lymph Node Mapping in Cutaneous Melanoma: A Pilot Study

Caitlin Bertelsen MD, Kevin G. King MD, Mark Swanson MD, Vinay Duddalwar MD, Jon?Paul Pepper MD

First published: 03 October 2018

https://doi.org/10.1002/lary.27397

Malignant Melanoma Cells and Hair Follicles: Focusing on Head and Neck Melanomas

Emi Dika, MD Giulia Veronesi, MD Cosimo Misciali, MD Barbara Corti, MDInes Dika, PhD Mattia Riefolo, MD Federica Scarfì, MD Martina Lambertini, MDAnnalisa Patrizi, MD

American Journal of Clinical Pathology, aqz029, https://doi.org/10.1093/ajcp/aqz029

Published: 24 April 2019

Future Medicine

MELANOMA MANAGEMENT AHEAD OF PRINT CASE SERIES

Re-biopsy of partially sampled thin melanoma impacts sentinel lymph node sampling as well as surgical margins

Evan S Weitman, Matthew C Perez, Daniel Lee, Youngchul Kim, William Fulp, Vernon K Sondak, Amod A Sarnaik, Ricardo J Gonzalez, Carl W Cruse, Jane L Messina & Jonathan S Zager

Published Online:26 Apr 2019https://doi.org/10.2217/mmt-2018-0011

Dove Press

Baseline platelet counts and derived inflammatory biomarkers: prognostic relevance in metastatic melanoma patients receiving Endostar plus dacarbazine and cisplatin

Authors Yang L, Xu Y, Luo P, Chen S, Zhu H, Wang C

Received 11 November 2018

Accepted for publication 1 April 2019

Published 29 April 2019 Volume 2019:11 Pages 3681—3690

DOI https://doi.org/10.2147/CMAR.S194176

Cancer Medicine

ORIGINAL RESEARCH

Open Access

DNA alteration?based classification of uveal melanoma gives better prognostic stratification than immune infiltration, which has a neutral effect in high?risk group

Deepti Narasimhaiah, Catherine Legrand, Diane Damotte, Romain Remark, Marco Munda, Patrick De Potter, Pierre G. Coulie, Miikka Vikkula, Catherine Godfraind

First published: 25 April 2019

https://doi.org/10.1002/cam4.2122

Dove Press

Fibronectin 1 promotes melanoma proliferation and metastasis by inhibiting apoptosis and regulating EMT

Authors Li B, Shen W, Peng H, Li Y, Chen F, Zheng L, Xu J, Jia L

Received 23 November 2018

Accepted for publication 9 March 2019

Published 1 May 2019 Volume 2019:12 Pages 3207—3221

DOI https://doi.org/10.2147/OTT.S195703

Journal of Clinical Investigation

SMAD signaling promotes melanoma metastasis independently of phenotype switching

Eylul Tuncer, Raquel R. Calçada, Daniel Zingg, Sandra Varum, Phil Cheng, Sandra N. Freiberger,Chu-Xia Deng, Ingo Kleiter, Mitchell P. Levesque, Reinhard Dummer, and Lukas Sommer

First published April 30, 2019 Free access | 10.1172/JCI94295

Melanoma Journal Articles for April 2019

Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5^?/^? mice

Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma

Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases

WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial–mesenchymal transition

Robotic-Assisted Pelvic Lymphadenectomy for Metastatic Melanoma Results in Durable Oncologic Outcomes

Nuclear Medicine and Molecular Imaging

Original Research

Tumor Heterogeneity on FDG PET/CT and Immunotherapy: An Imaging Biomarker for Predicting Treatment Response in Patients With Metastatic Melanoma

Stromal inflammatory cells are associated with poorer prognosis in primary cutaneous melanoma

Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis

Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis

Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity

Benefits of a brief psychological intervention targeting fear of cancer recurrence in people at high risk of developing another melanoma: 12-month follow-up results of a randomised controlled trial.

Wide local excision prior to sentinel lymph node biopsy for primary melanoma of the head and neck

SPINT1 regulates the aggressiveness of skin cutaneous melanoma and its crosstalk with tumor immune microenvironment

Patterns of recurrence and retreatment outcomes among clinical stage I and II head and neck melanoma patients

Application of CO₂ laser evaporation in locally advanced melanoma

Hypophysitis induced by immune checkpoint inhibitors in a Scottish melanoma population

Contrast?Enhanced Ultrasound With Perflubutane for Sentinel Lymph Node Mapping in Cutaneous Melanoma: A Pilot Study

Malignant Melanoma Cells and Hair Follicles: Focusing on Head and Neck Melanomas

Re-biopsy of partially sampled thin melanoma impacts sentinel lymph node sampling as well as surgical margins

Baseline platelet counts and derived inflammatory biomarkers: prognostic relevance in metastatic melanoma patients receiving Endostar plus dacarbazine and cisplatin

DNA alteration?based classification of uveal melanoma gives better prognostic stratification than immune infiltration, which has a neutral effect in high?risk group

SMAD signaling promotes melanoma metastasis independently of phenotype switching

Eylul Tuncer, Raquel R. Calçada, Daniel Zingg, Sandra Varum, Phil Cheng, Sandra N. Freiberger,Chu-Xia Deng, Ingo Kleiter, Mitchell P. Levesque, Reinhard Dummer, and Lukas Sommer

Our Partners

Melanoma Research Victoria

Quick Links

Melanoma Journal Articles for April 2019

Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5?/? mice

Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanoma

Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases

WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial–mesenchymal transition

Robotic-Assisted Pelvic Lymphadenectomy for Metastatic Melanoma Results in Durable Oncologic Outcomes

Nuclear Medicine and Molecular Imaging

Original Research

Tumor Heterogeneity on FDG PET/CT and Immunotherapy: An Imaging Biomarker for Predicting Treatment Response in Patients With Metastatic Melanoma

Stromal inflammatory cells are associated with poorer prognosis in primary cutaneous melanoma

Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis

Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis

Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity

Benefits of a brief psychological intervention targeting fear of cancer recurrence in people at high risk of developing another melanoma: 12-month follow-up results of a randomised controlled trial.

Wide local excision prior to sentinel lymph node biopsy for primary melanoma of the head and neck

SPINT1 regulates the aggressiveness of skin cutaneous melanoma and its crosstalk with tumor immune microenvironment

Patterns of recurrence and retreatment outcomes among clinical stage I and II head and neck melanoma patients

Application of CO2 laser evaporation in locally advanced melanoma

Hypophysitis induced by immune checkpoint inhibitors in a Scottish melanoma population

Contrast?Enhanced Ultrasound With Perflubutane for Sentinel Lymph Node Mapping in Cutaneous Melanoma: A Pilot Study

Malignant Melanoma Cells and Hair Follicles: Focusing on Head and Neck Melanomas

Re-biopsy of partially sampled thin melanoma impacts sentinel lymph node sampling as well as surgical margins

Baseline platelet counts and derived inflammatory biomarkers: prognostic relevance in metastatic melanoma patients receiving Endostar plus dacarbazine and cisplatin

DNA alteration?based classification of uveal melanoma gives better prognostic stratification than immune infiltration, which has a neutral effect in high?risk group

SMAD signaling promotes melanoma metastasis independently of phenotype switching

Eylul Tuncer, Raquel R. Calçada, Daniel Zingg, Sandra Varum, Phil Cheng, Sandra N. Freiberger,Chu-Xia Deng, Ingo Kleiter, Mitchell P. Levesque, Reinhard Dummer, and Lukas Sommer

Our Partners

Melanoma Research Victoria

Quick Links

Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5^?/^? mice

Application of CO₂ laser evaporation in locally advanced melanoma